A critical role of IL-33 in experimental allergic rhinitis-Reference-Cited by-同舟云学术

A critical role of IL-33 in experimental allergic rhinitis

Published:2012-07 Issue:1 Volume:130 Page:184-194.e11
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Haenuki Yoko,Matsushita Kazufumi,Futatsugi-Yumikura Shizue,Ishii Ken J.,Kawagoe Tatsukata,Imoto Yoshimasa,Fujieda Shigeharu,Yasuda Makoto,Hisa Yasuo,Akira Shizuo,Nakanishi Kenji,Yoshimoto Tomohiro

Funder

Takeda Science Foundation

Japan Society for the Promotion of Science

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference64 articles.

1. Global alliance against chronic respiratory diseases;Bousquet;Allergy,2007

2. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis;Skoner;J Allergy Clin Immunol,2001

3. The spectrum of allergens in ragweed and mugwort pollen;Wopfner;Int Arch Allergy Immunol,2005

4. Ragweed (Ambrosia) progression and its health risks: will Switzerland resist this invasion?;Taramarcaz;Swiss Med Wkly,2005

5. Recent warming by latitude associated with increased length of ragweed pollen season in central North America;Ziska;Proc Natl Acad Sci U S A,2011

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The production, function, and clinical applications of IL-33 in type 2 inflammation-related respiratory diseases;Frontiers in Immunology;2024-09-05

2. V Brazilian Consensus on Rhinitis – 2024;Brazilian Journal of Otorhinolaryngology;2024-09

3. Chemical respiratory sensitization—Current status of mechanistic understanding, knowledge gaps and possible identification methods of sensitizers;Frontiers in Toxicology;2024-07-29

4. Intranasal administration of ceramide liposome suppresses allergic rhinitis by targeting CD300f in murine models;Scientific Reports;2024-04-10

5. A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability After Subcutaneous Administration of Tozorakimab in Healthy Chinese Participants;Clinical Pharmacology in Drug Development;2024-03-25